GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
Cardiovascular Systems Inc. (CSII) [hlAlert]

Rating:
Buy CSII
up 258.35 %

Cardiovascular Systems Inc. (CSII) rated Buy by Feltl & Co.

Posted on: Friday,  Oct 7, 2011  9:25 AM ET by Feltl & Co.

Feltl & Co. rated Buy Cardiovascular Systems Inc. (NASDAQ: CSII) on 10/07/2011. Previously Feltl & Co. rated Buy Cardiovascular Systems Inc. (NASDAQ: CSII)
on 05/29/2009., when the stock price was $6.70. Since then, Cardiovascular Systems Inc. has gained 258.36% as of 01/22/2016's recent price of $24.01.
If you would have followed the previous Feltl & Co.'s recommendation on CSII, you would have gained 258.35% of your investment in 2429 days.

Cardiovascular Systems, Inc.(CSI) is a medical device company focused on developing and commercializing minimally invasive treatment solutions for vascular disease. The Company?s primary product, the Diamondback 360 PAD System, is a catheter-based platform capable of treating a range of plaque types in leg arteries both above and below the knee. In August 2007, the United States Food and Drug Administration (FDA) granted the Company 510(k) clearance for use of the Diamondback 360 as a therapy for treatment of patients with peripheral artery disease (PAD). As of June 30, 2009, it was selling the Diamondback 360 in 556 accounts that had completed an estimated 15,000 procedures. On February 25, 2009, Replidyne, Inc. completed its merger with Cardiovascular Systems, Inc. Pursuant to the merger, Replidyne merged with and into Cardiovascular Systems, Inc., with Cardiovascular Systems, Inc. continuing after the merger as the surviving company and a wholly owned subsidiary of Replidyne.

Feltl and Company's Research Department is focused on micro to small market capitalization companies that are not widely covered by other research firms. Our research universe is focused and organized around the sectors of Technology, HealthCare, and Leisure/Consumer. Feltl and Company holds its research department to very high standards, and strives to provide value- added investment ideas through sound fundamental analysis. Feltl and Company's Research Department includes six senior analysts and one associate analyst with many years of investment analysis experience. Although we are focused on, and committed to, companies in the Upper Midwest, our reach extends from coast to coast. About half of the companies we cover are headquartered outside our "backyard." Our analysts have significant industry experience and strive to know their companies inside and out. Through stringent analysis, they provide value by creating a disciplined application of company valuation, allowing our clients to make sound investment decisions.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
10/31/2013 3:25 PM Buy
None
30.53 35.00
as of 12/30/2011
1 Week down  -1.30 %
1 Month down  -4.27 %
3 Months down  -13.52 %
1 YTD down  -15.52 %
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
10/23/2013 12:25 PM Buy
None
28.28 32.50
8/8/2013 9:25 AM Buy
None
22.02 27.50
10/7/2011 9:25 AM Buy
None
8.95
5/29/2009 10:25 AM Buy
None
6.70 13.00

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy